Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.2%

7 terminated/withdrawn out of 217 trials

Success Rate

88.3%

+1.8% vs industry average

Late-Stage Pipeline

18%

38 trials in Phase 3/4

Results Transparency

4%

2 of 53 completed trials have results

Key Signals

53 recruiting2 with results

Enrollment Performance

Analytics

N/A
108(67.5%)
Phase 4
29(18.1%)
Phase 3
9(5.6%)
Early Phase 1
7(4.4%)
Phase 2
6(3.8%)
Phase 1
1(0.6%)
160Total
N/A(108)
Phase 4(29)
Phase 3(9)
Early Phase 1(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (217)

Showing 20 of 217 trials
NCT07570160Phase 4Not Yet Recruiting

Intranasal Dexmedetomidine or Esketamine for Negative Postoperative Behavioral Changes in Children

Role: collaborator

NCT07537296Recruiting

Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction

Role: lead

NCT05397405Not ApplicableRecruiting

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

Role: lead

NCT04175691Recruiting

Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)

Role: lead

NCT07349979Not ApplicableNot Yet Recruiting

PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy

Role: lead

NCT03852082Active Not Recruiting

Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention

Role: lead

NCT03971500Not ApplicableActive Not Recruiting

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

Role: lead

NCT03770650Not ApplicableActive Not Recruiting

IVUS-guided DK Crush Stenting Technique for Patients With Complex Bifurcation Lesions

Role: lead

NCT07306988Phase 4Recruiting

Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.

Role: lead

NCT05410457Recruiting

Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)

Role: lead

NCT04230785Recruiting

Circulating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)

Role: lead

NCT07455448Completed

Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study

Role: lead

NCT04864145Not ApplicableRecruiting

Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation

Role: lead

NCT07505056Phase 3Not Yet Recruiting

Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas

Role: lead

NCT07466251Phase 4Not Yet Recruiting

PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

Role: collaborator

NCT07093788Not ApplicableRecruiting

Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions

Role: lead

NCT06340334Not ApplicableCompleted

Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study

Role: lead

NCT07083154Phase 3Recruiting

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Role: collaborator

NCT06412588Not ApplicableCompleted

Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.

Role: lead

NCT06340724Phase 3Completed

Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication

Role: lead